chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Soreness and weakness of the left arm.; Soreness and weakness of the left arm.; This is a spontaneous report from a contactable other health professional (patient). A 28-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL9245, Expiration date: unknown) intramuscular on left arm on 30Jan2021 at 07:45 AM at a single dose for covid-19 immunisation. The patient medical history was not reported. The patient has no allergies to medications, food, or other products. The patient was not pregnant at the time of vaccination. Concomitant medication which the patient received within 2 weeks of vaccination included acetaminophen and ibuprofen. The patient experienced soreness and weakness of the left arm on 30Jan2021 at 12:00 PM. The most recent COVID-19 vaccine was administered in hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and since the vaccination, the patient was not been tested for COVID-19. The patient did not received treatment for the adverse events. The patient has not recovered from soreness and weakness of the left arm.
light mild headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 01Apr2021 (Lot number: EP7533) at the age of 49 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset Apr2021, outcome "recovered" (Apr2021), described as "light mild headache". Therapeutic measures were taken as a result of headache.  Additional information: The patient took the first Pfizer shot on 01Apr2021. The patient had a little mild side effect, like a slight headache, nothing at all. The patient took Aspirin and Tylenol and was fine.  No follow-up attempts are possible. No further information is expected.
Approximately 28 hours after receiving vaccination he noticed that he lost his sense of taste. He states he can still smell.
Information has been received from a registered nurse referring to multiple unspecified patients of unknown age and gender. Information regarding concomitant medications, medical history and drug reactions/allergies was not reported. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX (lot #, expiration date, dose and route were not reported). No adverse effects were reported. Additional information has been requested.
Itchy, red area about 3x3 at site. Developed a couple days ago. I did not have any side effect when the injection given, other than a bit of soreness at site. Will follow. Read about others having this issue when I checked the websites. Will go ahead and have the scheduled second injection in a couple weeks. Suppose just a good sign my immune system is working? But thought any reactions should be shared with CDC or Maderna as part of their ongoing research.
This report described the occurrence of fever in a male pt who reportedly received Lyme disease vaccine recombinant as part of a clinical trial of compound 215274. This report was received as part of litigation proceedings, and has not been verified by a physician or other health care professional. The pt received injections of LYMErix on5/13/98, 6/8/98 and 5/5/99 "according to his medical records." On 9/3/03, the pt's attorney alleged that the pt "has complaint of fever and chills according to his medical records." Time to onset from immunization was not reported. Limited medical records Limited medical records supplied by the attorney indicated that the pt was treated with amoxicillin on 9/17/02, Zithromax on 9/17/02 and Mepron on an unspecified date. Outcomes of the alleged events were not reported.
The syringe was not attached to the needle during injection. A good amount of the vaccine leaked out of the syringe during injection. The correct dose was given right after the event.
Booster shot. Had a rash that lasted approx. a week after vaccination. Swollen lymph node in armpit, too. Rash was the size of a grapefruit, itchy, swollen, red, and hot. I went to my Doctor's office again just to get it checked out. She advised it was a normal, localized reaction and to take Benadryl along with hydrocortisone cream to help with the itchiness. It went away after about a week.
improperly stored vaccine administered; no adverse effect; This spontaneous report as received from an office manager refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.       On an unknown date, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # S021925, expiry date : 15-JUL-2021) for prophylaxis. Other suspect therapies included sterile diluent(MERCK STERILE DILUENT). It was unknown if diluent used to reconstitute was stored at proper temperature.    It was reported that the vaccine experienced a temperature excursion total time in the range of 6 degrees Fahrenheit (F) to 14 degrees F (-14 degrees Celsius (C) to - 10 degrees C) for 30 minutes, 15 degrees F to 46 degrees F (-9 degrees C to 8 degrees C) for 7 hours and 47 degrees F to 77 degrees F (9 degrees C to 25 degrees C) for 9 hours (product storage error). There was no previous temperature excursion and it was reported that this call was due to a digital data logger. The patient had no adverse events. There was no product quality compliant involved.   This is one of the several reports received from the same reporter.; Sender's Comments:  US-009507513-2001USA005705:Original Case : 2001USA005586 US-009507513-2001USA005680:Original Case : 2001USA005586 US-009507513-2001USA005703:Original Case : 2001USA005586 US-009507513-2001USA005686:Original Case : 2001USA005586 US-009507513-2001USA005688:Original Case : 2001USA005586 US-009507513-2001USA005691:Original Case : 2001USA005586 US-009507513-2001USA005685:Original Case : 2001USA005586 US-009507513-2001USA005684:Original Case : 2001USA005586 US-009507513-2001USA005687:Original Case : 2001USA005586 US-009507513-2001USA005678:Original Case : 2001USA005586 US-009507513-2001USA005707:Original Case : 2001USA005586 US-009507513-2001USA005704:Original Case : 2001USA005586 US-009507513-2001USA005701:Original Case : 2001USA005586 US-009507513-2001USA005699:Original Case : 2001USA005586 US-009507513-2001USA005697:Original Case : 2001USA005586 US-009507513-2001USA005696:Original Case : 2001USA005586 US-009507513-2001USA005682:Original Case : 2001USA005586 US-009507513-2001USA005690:Original Case : 2001USA005586 US-009507513-2001USA005698:Original Case : 2001USA005586 US-009507513-2001USA005681:Original Case : 2001USA005586 US-009507513-2001USA005702:Original Case : 2001USA005586 US-009507513-2001USA005695:Original Case : 2001USA005586 US-009507513-2001USA005689:Original Case : 2001USA005586 US-009507513-2001USA005683:Original Case : 2001USA005586
Patient immediately had a strange taste in his mouth and a horrible headache. He was dizzy for a short time. Recovered after 20 minutes but still had headache.
Severe Redness and swelling beginning evening of vaccine; Fever, chills, and severe fatigue day after vaccine; most symptoms resolved by time reported 8/23/19 @4:15P
This case was reported by a consumer via call center representative and described the occurrence of neurological disorder nos in a male patient who received ENGERIX B. On an unknown date, the patient received ENGERIX B at an unknown dose. On an unknown date, an unknown time after receiving ENGERIX B, the patient experienced neurological disorder nos. On an unknown date, the outcome of the neurological disorder nos was not recovered/not resolved. It was unknown if the reporter considered the neurological disorder nos to be related to ENGERIX B. Additional details provided were as follows: This case was reported by the patient himself. The patient reported about experiencing some reactions (neurological disorder) to ENGERIX B vaccine. No further information was available.
Severe arm pain - from shoulder to elbow and into armpit.  Nauseous all night that  did not turn to vomiting but felt I could vomit.  Slight chills.  Joint aches on left side.
Information has been received on 13-APR-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 20-FEB-2014, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route, at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. On or about 20-JUN-2017, the patient was treated at a health facility for a vesicular outbreak which was diagnosed as herpes zoster, or shingles. The patient has been prescribed acyclovir, gabapentin, and lidocaine gel for management of her painful symptoms. As a direct and proximate result of the ZOSTAVAX, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Fever, chills, vomiting, cough, diarrhea, painful lump at injection site, fatigue
7 total vesiculopapular lesions on back/ext/abdomen after receiving varicella vaccine. No fever, no cough, no congestion.
local site reaction beginning <24 h post vaccination. Tx with compress/BENADRYL
covid arm; I had a tennis-ball-sized circle a few inches below the injection; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (covid arm) and INJECTION SITE REACTION (I had a tennis-ball-sized circle a few inches below the injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced LIMB DISCOMFORT (covid arm) and INJECTION SITE REACTION (I had a tennis-ball-sized circle a few inches below the injection). At the time of the report, LIMB DISCOMFORT (covid arm) and INJECTION SITE REACTION (I had a tennis-ball-sized circle a few inches below the injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Patient came in on 10/7/2018 to get a flu vaccine and before I gave him the vaccine he asked that I be careful to not inject the vaccine to high on his shoulder because when he got the PNEUMOVAX 23 vaccine on 9/26/2018 he thought the injection was too high and close to the joint. He said that he could not raise his arm for two days and after that his shoulder was fine.
This study case was received from the investigator in a trial on 05 February 2013. A 20 year-old male subject (date of birth not reported) with no reported past medical history had received on 16 May 2012 in the right arm a ACAM2000, (lot number and route of administration not reported) and 8 days later was found to have on 24 May 2012 chest pain. The subject also received on 03 May 2012 Anthrax vaccine (manufacturer, lot number, route and site of administration not reported). On 28 May 2012, the subject was evaluated where he reported chest pain with cold sweats. The subject described the chest pain was like a pressure that lasted a few minutes on and off throughout the day. He also reported vision disturbance of speckled vision. The subject rested for about five minutes the events subsided shortly after on 24 May 2012. The subject had no other signs or symptoms of myopericarditis. He did not seek medical attention. A Troponin level was drawn, rapid test was negative and the level was normal. The subject had an ECG which was normal. No further information was available at the time of the report. The subject's outcome was recovered/resolved on 28 May 2012. According to the investigator the event of chest pain was considered to be possibly related. Documents held by sender: progress notes.
Fever (24 hours+ of over 101), headache, fatigue, extreme nausea, dizziness, 1 episode of loss of consciousness (fainting), profuse sweating, rash covering trunk, neck, arms for 3+ days. 2 days of work missed.
Pt reported nausea, vomiting, generalized body aches, headache that began 10/21/03 (2 days after receiving vaccine).
Patient experience overall body aches the day following the vaccination. She had adverse effects all the way up until the 2nd dose of the vaccination. She did not seek medical attention or let us know of any issues until after getting her 2nd shot. She described the issue as arm soreness/stiffness in both arms to the point it affected everyday life. She had trouble lifting arms and putting on clothing.
This spontaneous report received from a consumer, concerning a 73-year-old male patient who received the Moderna COVID-19 (mRNA-1273) vaccine and experienced: legs felt a little weak/no strength in his legs, felt like he had no muscles in his legs and fell twice. The patient's medical history, current condition and concomitant medications not provided. On Jan 26, 2021, prior to the onset of events, patient received the first of two planned doses of mRNA-1273 (lot/batch# 031L20A), via unknown route, in the left arm, for prophylaxis of COVID-19 infection. On Jan 27, 2021, patient experienced: legs felt a little weak/no strength in his legs and felt like he had no muscles in his legs. On Jan 28, 2021, patient experienced a fall. No treatment information provided. Action taken with mRNA-1273 in response to the events not reported. On Jan 29, 2021 the outcome of legs felt a little weak/no strength in his legs, felt like he had no muscles in his legs and fell twice resolved.
No adverse events/no signs or symtoms reported; temperature excursion on VARlVAX / Improperly Stored Administer Vaccine; This spontaneous report as received from a consumer (reported also as administrator) referring to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant therapies and drug reactions and allergies were not reported  On 25-MAR-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) (strength, route of administration, site of administration) (lot # T025946, expiration date 30-JUL-2020) 0.5 milliliter for prophylaxis.         On 25-MAR-2021, the vaccine underwent a temperature excursion of 11.5-degree Fahrenheit (F) for a period of 1 hour and 10 minutes. The excursion was not called by a digital data logger and there was no history of previous temperature excursion. The patient did not experience any adverse event.; Sender's Comments:  US-009507513-2104USA000804: US-009507513-2104USA000804:
Tingling and heaviness in extremities, muscle weakness (+) Guillain-Barre. (Recurrence, prior event 17 yr ago).
HPV 0.5 ml IM R Deltoid, Pt with syncopal episode once head trauma. MD eval to pt. Tylenol given for HA. Pt with nausea/vomiting-CT ordered
Pt broke out in hives all over her body about 2am the day after the immunizations. Parents gave Benadryl which decreased the size of the welts for about 1 hour after each dose. Hives decreased in size and severity about 4 days after onset and a few lingered for a few more days. They were completely gone 7 days after onset.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 39-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    concomitant medications are not provided by the reporter  no treatment information provided   This case was linked to MOD21-126929 (Patient Link).
Patient experienced right-sided weakness 24 hours after Moderna vaccine received.  He did not seek medical attention until 3/11/21, at which time he was hospitalized and diagnosed with a CVA.
mom reports about 30 minutes after child received MMR child's face was brightly flushed, had bright fine rash down left arm, on chest, on abdomen and some on the back. States child experienced some complaining of abdominal cramping at times on 08/15/2005. Treatment Benadryl 1/2 tsp. States on 08/16/05 child feels good -  playful, eating well. States rash very light today.
4/14/21 11:00pm injectionsite discomfort.  2:00pm 4/15/21 started to feel slightly sick with body aches and headache.  The bodyaches increased in intensity until 9:00pm when they were very severe in nature all over.  4/15/21 9:00pm my body was freezing cold, could not get warm and severe body pain unti 4/16/21 at 1:00 am.  4/16/21 1:00 am for next approximate 23 hours I continued with moderate to mild bodyaches and headahe.  4/17/21 injection area redness, hot and sore
Varicella-zoster virus: > 50 2-3mm red papules on back of neck, trunk, arms in varynig stages. Also, 1x3 cm abrasion on (L) elbow with yellow crust, cellulitis treated with KEFLEX. Itching began a few days ago. Rash 4/14/14. T. 98.0 degrees F temp.
Breakthrough COVID-19 infection. Tested positive on 08/27/2021. Patient fully vaccinated on 02/20/2021.
Red, hot area on arm where she got shot. Told to take BENADRYL.
Immediately post vax, the pt developed a red whelp at injection site, 1 cm across. Treated with Benadryl and ice.
Chills, fever, nausea, muscle ache, headache, sinus issues, very tired
Exceeded the 20 puncture limit on a vial of Moderna Covid-19 Vaccine for booster doses for 1 or 2 patients with 1 vial; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Exceeded the 20 puncture limit on a vial of Moderna Covid-19 Vaccine for booster doses for 1 or 2 patients with 1 vial) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Exceeded the 20 puncture limit on a vial of Moderna Covid-19 Vaccine for booster doses for 1 or 2 patients with 1 vial). At the time of the report, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Exceeded the 20 puncture limit on a vial of Moderna Covid-19 Vaccine for booster doses for 1 or 2 patients with 1 vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were mentioned.  No treatment details were reported.
dozens of Hives, extremely small, around 100+ on each arm, mildly itchy on neck, upper forearms, and elbows.
patient got a dose from and expired vial; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient got a dose from and expired vial) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient got a dose from and expired vial). On 18-Oct-2021, EXPIRED PRODUCT ADMINISTERED (patient got a dose from and expired vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported.
Patient came to clinic and received two doses of Fluzone High Dose in clinic. One was administered while the patient was in the rooming process and another occurred once the patient was preparing to leave and was receving their COVID booster at that time. The patient was then told to wait an additional 20 minutes for observation for adverse events and none were documented and the patient was discharged home at that time.